Share on LinkedInShare on LinkedIn

ARTICLE · 12 FEBRUARY 2026

Single‑Reference Disclosures And The Motivation‑To‑Combine Requirement

In January 2026, the Federal Circuit issued a nonprecedential opinion in Guardant Health, Inc. v. University of Washington (Slip Op. 2024-1129, Jan. 23, 2026) that, while not binding precedent, is nevertheless highly relevant to patent practice in any technology.

United StatesIntellectual Property

In January 2026, the Federal Circuit issued a nonprecedential opinion in Guardant Health, Inc. v. University of Washington (Slip Op. 2024-1129, Jan. 23, 2026) that, while not binding precedent, is nevertheless highly relevant to patent practice in any technology. The patent at issue, U.S. Patent No. 10,760,127, claims methods for reducing sequencing errors using Duplex Consensus Sequencing (DCS), a technique that pairs double-stranded DNA with unique molecular identifiers before amplification and sequencing. This approach is designed to achieve unprecedented sensitivity in detecting rare variants, a capability critical to applications like early cancer detection and other high-stakes medical diagnostics.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from